(2019) Relationship between Resistin, Endothelin-1, and Flow-Mediated Dilation in Patient with and without Metabolic Syndrome. Adv Biomed Res. p. 16. ISSN 2277-9175 (Print) 2277-9175 (Linking)
|
Text
10603.pdf Download (589kB) | Preview |
Abstract
Background: Resistin is peptides that signal the functional status of adipose tissue to the brain and other target organs. It causes insulin resistance and affects the vascular endothelial dysfunction. However, the function and relation between resistin in endothelin-1 (ET-1), which leads to the endothelial dysfunction in humans are enigmatic. Materials and Methods: In a cross-sectional study of 76 participants (38 metabolic syndrome patients and 38 healthy participants), biochemical and clinical parameters, including lipid profile, fasting glucose, resistin, ET-1, C-reactive protein (CRP), flow-mediated dilation (FMD), and hypertension were determined and compared between the two groups. Results: Multiple linear regression analysis was performed with age- and sex-adjusted plasma resistin levels, FMD, and ET-1 as the dependent variables. Analysis showed that weight, body mass index, triglycerides (TGs), and ET-1 were statistically significant correlated with serum resistin. FMD has negative significantly correlated with weight (r = -0.491, P = 0.001), waist circumference (r = -0.491, P = 0.001), waist-to-hip ratio (r = -0.0444, P = 0.001), and ET-1 (r = -0.075, P = 0.050), but it has significantly correlated with systolic blood pressure (SBP) (r = 0.290, P = 0.016), diastolic blood pressure (DBP) (r = 0.275, P = 0.023), and high-density lipoprotein cholesterol (HDL-C) (r = -0.266, P = 0.050), and ET-1, but it has significantly correlated with SBP, DBP, and HDL-C. ET-1 is significantly correlated with TGs (r = -0.436, P = 0.006), total cholesterol (r = 0.452, P = 0.004), low-density lipoprotein cholesterol (r = 0.454, r = 0.004), and resistin (r = 0.282, P = 0.050), whereas it has negative significantly correlated with HDL-C (r = 0.346, P = 0.034), FMD (r = -0.075, P = 0.050. Conclusion: In this study, results shown plasma ET-1 and resistin are suggested as risk factors for the development of endothelial dysfunction and with further study, it is possible that can diagnose the risk of diabetes and cardiovascular disease in the early stages.
Item Type: | Article |
---|---|
Keywords: | Endothelin-1 flow-mediated dilation metabolic syndrome resistin |
Subjects: | WD Disorders of Systemic, Metabolic or Environmental Origin, etc. > WD 200-226 Metabolic Diseases |
Divisions: | Cardiovascular Research Institute > Heart Failure Research Center Cardiovascular Research Institute > Hypertension Research Center Cardiovascular Research Institute > Isfahan Cardiovascular Research Center Faculty of Pharmacy and Pharmaceutical Sciences > Department of Clinical Biochemistry Isfahan Pharmaceutical Sciences Research center |
Page Range: | p. 16 |
Journal or Publication Title: | Adv Biomed Res |
Journal Index: | Pubmed |
Volume: | 8 |
Identification Number: | https://doi.org/10.4103/abr.abr₁₂₆₁₈ |
ISSN: | 2277-9175 (Print) 2277-9175 (Linking) |
Depositing User: | Zahra Otroj |
URI: | http://eprints.mui.ac.ir/id/eprint/10603 |
Actions (login required)
View Item |